110 related articles for article (PubMed ID: 33033581)
1. Exploration of gastric neuroendocrine carcinoma (GNEC) specific signaling pathways involved in chemoresistance via transcriptome and
Xie J; Chen P; Xie H; Sun Y; Huang Z; Wei R; Miao Z; Wang Q; Zhang SD; Wong KH; Lin Y; Huang C; Kwok HF
Comput Struct Biotechnol J; 2020; 18():2610-2620. PubMed ID: 33033581
[TBL] [Abstract][Full Text] [Related]
2. Better Prognosis of Gastric Neuroendocrine Carcinoma Than Gastric Adenocarcinoma among Whites in the United States: A Propensity Score Matching Analysis Based on SEER.
Li Z; Ren H; Zhao L; Zhang X; Wang T; Sun C; Niu P; Wang W; Fei H; Guo C; Chen Y; Zhao D
Curr Oncol; 2022 Jul; 29(7):4879-4892. PubMed ID: 35877247
[TBL] [Abstract][Full Text] [Related]
3. RUNDC3A regulates SNAP25-mediated chemotherapy resistance by binding AKT in gastric neuroendocrine carcinoma (GNEC).
Chen P; Wang W; Wong SW; Li J; Wu Q; Zhang SD; Lin Y; Kwok HF
Cell Death Discov; 2022 Jun; 8(1):296. PubMed ID: 35752613
[TBL] [Abstract][Full Text] [Related]
4. CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signaling.
Lin JX; Weng XF; Xie XS; Lian NZ; Qiu SL; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Yang YH; Liu SJ; Hu M; Lin YK; Huang CM; Zheng CH; Li P; Xie JW
Cancer Cell Int; 2019; 19():282. PubMed ID: 31728130
[TBL] [Abstract][Full Text] [Related]
5. RUNDC3A/SNAP25/Akt signaling mediates tumor progression and chemoresistance in gastric neuroendocrine carcinoma.
Lin Z; Kwok HF
Cell Death Dis; 2022 Oct; 13(10):840. PubMed ID: 36182960
[TBL] [Abstract][Full Text] [Related]
6. Different long-term oncologic outcomes after radical surgical resection for neuroendocrine carcinoma and adenocarcinoma of the stomach.
Xie JW; Lu J; Lin JX; Zheng CH; Li P; Wang JB; Chen QY; Cao LL; Lin M; Tu RH; Huang CM
Oncotarget; 2017 Aug; 8(34):57495-57504. PubMed ID: 28915689
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and genetic characteristics of gastric neuroendocrine tumour (NET) G3 and comparisons with neuroendocrine carcinoma and NET G2.
Chen S; Sun L; Chen H; Li J; Lu C; Yang Y; Sun Y
Histopathology; 2023 Nov; 83(5):700-711. PubMed ID: 37403531
[TBL] [Abstract][Full Text] [Related]
8. Mixed large and small cell neuroendocrine carcinoma of the stomach: A case report and review of literature.
Li ZF; Lu HZ; Chen YT; Bai XF; Wang TB; Fei H; Zhao DB
World J Clin Cases; 2022 Jun; 10(16):5502-5509. PubMed ID: 35812663
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of clinicopathological factors related to the prognosis of gastric neuroendocrine carcinoma.
Xie JW; Sun YQ; Feng CY; Zheng CH; Li P; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Yang YH; Huang CM
Eur J Surg Oncol; 2016 Oct; 42(10):1464-70. PubMed ID: 27570115
[TBL] [Abstract][Full Text] [Related]
10. MiR-96-5p inhibition induces cell apoptosis in gastric adenocarcinoma.
Zhou HY; Wu CQ; Bi EX
World J Gastroenterol; 2019 Dec; 25(47):6823-6834. PubMed ID: 31885423
[TBL] [Abstract][Full Text] [Related]
11. Expression, Location, Clinical Implication, and Bioinformatics Analysis of RNASET2 in Gastric Adenocarcinoma.
Zeng Z; Zhang X; Li D; Li J; Yuan J; Gu L; Xiong X
Front Oncol; 2020; 10():836. PubMed ID: 32528897
[No Abstract] [Full Text] [Related]
12. Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer.
Yu J; Wang S; Zhao W; Duan J; Wang Z; Chen H; Tian Y; Wang D; Zhao J; An T; Bai H; Wu M; Wang J
Clin Cancer Res; 2018 May; 24(9):2148-2158. PubMed ID: 29437792
[No Abstract] [Full Text] [Related]
13. [Efficacy evaluation of laparoscopic D2 radical gastrectomy in gastric neuroendocrine carcinoma].
Xie J; Huang C; Zheng C; Li P; Wang J; Lin J; Lu J; Chen Q; Cao L; Lin M; Tu R
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Aug; 19(8):907-11. PubMed ID: 27545466
[TBL] [Abstract][Full Text] [Related]
14. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
Zhang J; Kou YB; Zhu JS; Chen WX; Li S
Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
[TBL] [Abstract][Full Text] [Related]
16. Superhydrophobic, photo-sterilize, and reusable mask based on graphene nanosheet-embedded carbon (GNEC) film.
Lin Z; Wang Z; Zhang X; Diao D
Nano Res; 2021; 14(4):1110-1115. PubMed ID: 33250970
[TBL] [Abstract][Full Text] [Related]
17. Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
Kou YB; Zhang SY; Zhao BL; Ding R; Liu H; Li S
Int J Immunopathol Pharmacol; 2013; 26(2):361-70. PubMed ID: 23755751
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes.
Li HL; Xie SP; Yang YL; Cheng YX; Zhang Y; Wang J; Wang Y; Liu DL; Chen ZF; Zhou YN; Wu HY
Asian Pac J Cancer Prev; 2015; 16(5):1781-7. PubMed ID: 25773825
[TBL] [Abstract][Full Text] [Related]
20. Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma.
Chen Y; Pang X; Ji L; Sun Y; Ji Y
Med Sci Monit; 2018 May; 24():3496-3505. PubMed ID: 29802710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
